Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions: Influenza, Human; Flu, Human; Flu, Avian; Influenza; Influenza A Virus, H5N1 SubtypeInterventions: Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Seasonal Influenza Vaccine; Biological: Novartis Seasonal Influenza VaccineSponsors: Novartis; Novartis VaccinesRecruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions: Influenza, Human; Flu, Human; Flu, Avian; Influenza; Influenza A Virus, H5N1 SubtypeInterventions: Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Seasonal Influenza Vaccine; Biological: Novartis Seasonal Influenza VaccineSponsors: Novartis; Novartis VaccinesRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2014 Category: Research Source Type: clinical trials